1614.1 – Magnetic resonance-guided focused ultrasound for the treatment of medically refractory essential tremor

Page last updated: 16 November 2021

Application Detail

Description of Medical Service

Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive, one-step method of targeted tissue thermal ablation used to treat medically refractory essential tremor (ET). The procedure combines focused ultrasound and magnetic resonance imaging to ablate the ventralis intermediate nucleus of the thalamus. The heat from MRgFUS causes a small lesion on the targeted spot on the thalamus, interrupting the abnormal activity associated with ET.

Description of Medical Condition

ET is a chronic, progressive neurological condition characterised by rhythmic and oscillatory tremors of the upper extremities, not attributable to another cause (e.g. Parkinson’s disease). Depending on disease severity, ET can lead to significant functional and social impairment.

Reason for Application

New MBS item

Medical Service Type

Therapeutic

Previous Application Number/s

1614

Associated Documentation

Application Form

-

Consultation Survey

Consultation Survey (PDF 182 KB)
Consultation Survey (Word 71 KB)

PASC Consultation
Not applicable

MSAC Consultation
MSAC consultation input must be received by no later than Friday, 11 February 2022 for it to be considered by MSAC at its March/April 2022 meeting.

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

Bypassing PASC

ESC

10-11 February 2022

MSAC

31 March-1 April 2022